Randomized Multicenter Trial of More Intense and Standard Early Verteporfin Treatment of Neovascular Age-Related Macular Degeneration

This publication has 14 references indexed in Scilit:

• Perspectives on Verteporfin Therapy Combined With Intravitreal Corticosteroids
  Archives of Ophthalmology (1950), 2006
• Comparison of Early Retreatment with the Standard Regimen in Verteporfin Therapy of Neovascular Age-Related Macular Degeneration
  Ophthalmology, 2005
• Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-Related Macular Degeneration
  Archives of Ophthalmology (1950), 2005
• Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration
  British Journal of Ophthalmology, 2005
• Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium–Derived Factor
  Investigative Opthalmology & Visual Science, 2003
• Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1
  American Journal of Ophthalmology, 2003
• Sequence of Early Vascular Events after Photodynamic Therapy
  Investigative Opthalmology & Visual Science, 2003
• Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes
  Albrecht von Graefes Archiv für Ophthalmologie, 2002
• Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration
  Archives of Ophthalmology (1950), 1999
• Some statistical methods for multiple endpoints in clinical trials
  Controlled Clinical Trials, 1997